Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 18.03.2024 2 BMJ 4 Clin Infect Dis 2 Infect Control Hosp Epidemiol 2 Int J Infect Dis 1 J Infect 6 J Med Virol 1 J Travel Med 3 J Virol 4 JAMA 3 Lancet 3 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 3 Nature 2 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. SHELTON J, Zotow E, Smith L, Johnson SA, et al
   25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
   BMJ. 2024;384:e076962.
   PubMed         Abstract available
   
   
2. WILKINSON E
   Covid inquiry: What we have learnt about Wales's response?
   BMJ. 2024;384:q608.
   PubMed        
   
   

   
   Clin Infect Dis

3. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
   Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine.
   Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
   PubMed         Abstract available
   
   
4. ROWAN CM, LaBere B, Young CC, Zambrano LD, et al
   Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
   Clin Infect Dis. 2024 Mar 11:ciae133. doi: 10.1093.
   PubMed         Abstract available
   
   
5. ROMINE JK, Li H, Coughlin MM, Jones JM, et al
   Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
   Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
   PubMed         Abstract available
   
   
6. HAYDEN MK, El Mikati IK, Hanson KE, Englund JA, et al
   Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.
   Clin Infect Dis. 2024 Mar 15:ciae121. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

7. NAKAGAWA M, Fujishiro Y, Doi Y, Yamakami J, et al
   Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2.
   Infect Control Hosp Epidemiol. 2024 Mar 14:1-3. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   
8. LI H, Sewell DK, Herman T, Pemmeraju SV, et al
   Comparing multiple infection control measures in a nursing home setting: a simulation study.
   Infect Control Hosp Epidemiol. 2024 Mar 15:1-8. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

9. BANDA L, Ho A, Kasenda S, Read JM, et al
   Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study.
   Int J Infect Dis. 2023;137:118-125.
   PubMed         Abstract available
   
   
10. HOSOZAWA M, Hori M, Hayama-Terada M, Arisa I, et al
    Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population.
    Int J Infect Dis. 2024 Mar 12:107008. doi: 10.1016/j.ijid.2024.107008.
    PubMed         Abstract available
    
    

    
    J Infect

11. MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, de Mendoza C, et al
    COVID-19 Mortality Amongst the Immunosuppresed.
    J Infect. 2024 Mar 11:106137. doi: 10.1016/j.jinf.2024.106137.
    PubMed        
    
    

    
    J Med Virol

12. 
    Correction to "Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting".
    J Med Virol. 2024;96:e29518.
    PubMed        
    
    
13. ZHENG Y, Feng J, Song Y, Yu Y, et al
    Design and synthesis of APN and 3CLpro dual-target inhibitors based on STSBPT with anticoronavirus activity.
    J Med Virol. 2024;96:e29512.
    PubMed         Abstract available
    
    
14. ROJO-ALBA S, Martinez ZP, Gonzalez-Alba JM, Boga JA, et al
    Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic.
    J Med Virol. 2024;96:e29499.
    PubMed         Abstract available
    
    
15. YEH LT, Chan CH, Wang YH, Lee CY, et al
    Exploring the incidence of peripheral arterial occlusive disease following COVID-19 infection: A retrospective cohort study.
    J Med Virol. 2024;96:e29519.
    PubMed         Abstract available
    
    
16. TAI CG, Haviland MJ, Kissler SM, Lucia RM, et al
    Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association.
    J Med Virol. 2024;96:e29505.
    PubMed         Abstract available
    
    
17. LEE C, Greenwood DC, Master H, Balasundaram K, et al
    Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study.
    J Med Virol. 2024;96:e29486.
    PubMed         Abstract available
    
    

    
    J Travel Med

18. QUIGLEY AL, Kunasekaran M, Stone H, Honeyman D, et al
    The impact of the cruise ship coral princess on COVID-19 transmission in regional Western Australia in 2022.
    J Travel Med. 2024 Mar 12:taae044. doi: 10.1093.
    PubMed        
    
    

    
    J Virol

19. LIU D, Cruz-Cosme R, Wu Y, Leibowitz J, et al
    2-Bromopalmitate depletes lipid droplets to inhibit viral replication.
    J Virol. 2024 Mar 15:e0017124. doi: 10.1128/jvi.00171.
    PubMed         Abstract available
    
    
20. BABOT M, Boulard Y, Agouda S, Pieri L, et al
    Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
    PubMed         Abstract available
    
    
21. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    PubMed         Abstract available
    
    

    
    JAMA

22. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    PubMed        
    
    
23. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    PubMed        
    
    
24. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    PubMed        
    
    
25. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    PubMed        
    
    

    
    Lancet

26. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed         Abstract available
    
    
27. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    PubMed        
    
    
28. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

29. ZHANG R, Hung IF
    Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising booster.
    Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00156.
    PubMed        
    
    
30. BENNETT C, Woo W, Bloch M, Cheung K, et al
    Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
    Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00077.
    PubMed         Abstract available
    
    
31. BILSEN MP, Conroy SP, Schneeberger C, Platteel TN, et al
    A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study.
    Lancet Infect Dis. 2024 Mar 5:S1473-3099(23)00778.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

32. YOUSAF AR, Lindsey KN, Wu MJ, Shah AB, et al
    Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:225-228.
    PubMed        
    
    

    
    Nature

33. MERIGGI NF, Voors M, Levine M, Ramakrishna V, et al
    Last-mile delivery increases vaccine uptake in Sierra Leone.
    Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07158.
    PubMed         Abstract available
    
    
34. BUTTENHEIM A, Thirumurthy H
    Mobile delivery of COVID-19 vaccines improved uptake in rural Sierra Leone.
    Nature. 2024 Mar 13. doi: 10.1038/d41586-023-03186.
    PubMed        
    
    
35. KOZLOV M
    Massive public-health experiment sends vaccination rates soaring.
    Nature. 2024 Mar 13. doi: 10.1038/d41586-024-00730.
    PubMed        
    
    

    
    Science

36. CROSS RW, Woolsey C, Chu VC, Babusis D, et al
    Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus.
    Science. 2024;383:eadk6176.
    PubMed         Abstract available
    
    
37. 
    Erratum for the Research Article "The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic" by M. Worobey et al.
    Science. 2024;383:eadp1133.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.